Cel-Sci
CVM
#9847
Rank
S$56.66 M
Marketcap
S$6.74
Share price
1.94%
Change (1 day)
-57.49%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of September 2025 : S$14.05 Million

According to Cel-Sci 's latest financial reports the company has S$14.05 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30S$14.13 M132.1%
2024-09-30S$6.08 M7.51%
2023-09-30S$5.66 M-82.6%
2022-09-30S$32.54 M-43.24%
2021-09-30S$57.33 M170.89%
2020-09-30S$21.16 M81.33%
2019-09-30S$11.67 M-17.2%
2018-09-30S$14.09 M337.75%
2017-09-30S$3.22 M-19.11%
2016-09-30S$3.98 M-51.16%
2015-09-30S$8.15 M-24.95%
2014-09-30S$10.86 M20697.75%
2013-09-30S$0.05 M-98.92%
2012-09-30S$4.84 M-12.48%
2011-09-30S$5.53 M-84.16%
2010-09-30S$34.94 M-26.45%
2009-09-30S$47.51 M3528.79%
2008-09-30S$1.3 M-91.93%
2007-09-30S$16.23 M26.48%
2006-09-30S$12.83 M287.81%
2005-09-30S$3.3 M-53.83%
2004-09-30S$7.16 M136.45%
2003-09-30S$3.03 M-18%
2002-09-30S$3.69 M-11.93%
2001-09-30S$4.19 M-77.39%
2000-09-30S$18.56 M85.12%
1999-09-30S$10.02 M-52.48%
1998-09-30S$21.1 M293.94%
1997-09-30S$5.35 M8.7%
1996-09-30S$4.92 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
S$11.61 M-17.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$0.27 B 1,843.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$12.12 B 86,128.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.60 B 4,200.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.82 B 20,012.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
S$23.82 B 169,361.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.31 B 2,141.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$3.91 M-72.18%๐Ÿ‡บ๐Ÿ‡ธ USA